Human Genetic Variation by National Institute of Health - HTML preview

PLEASE NOTE: This is an HTML preview only and some elements such as links or page numbers may be incorrect.
Download the book in PDF, ePub, Kindle for a complete version.

Introduction

of human genetic variation to a fictional case study involving a potentially

painful set of decisions that various members of a family have to make.

Groups of students analyze the case of a woman, Beth, who is concerned

that she may carry a variant of either the BRCA1 or BRCA2 gene that

predisposes people to breast cancer. The case study is presented in five

segments during which Beth makes two key decisions: (1) to proceed with

being tested for altered forms of these genes and (2) after she develops

cancer in one breast, not to have a prophylactic mastectomy of the other

breast. Students analyze each segment by discussing a set of questions

related to the underlying science and to the ethical and policy dilemmas

raised by the decisions.

The lesson’s fundamental purpose is to help students see that an under-

standing of science and a clear, systematic analysis of options can

help us make decisions in uncertain circumstances. Beth has a family

history of breast cancer, a form of cancer that kills more than 40,000

women in the United States each year. Information about the presence

of the altered gene could help her and her physician be more alert to

the possibilities of her developing cancer.

On the other hand, she is already practicing the guidelines recommended to

increase the chance of early detection should cancer develop. Furthermore,

as students learn, breast cancer related to the presence of an inherited

altered gene accounts for only 5 percent of the new cases of breast cancer

diagnosed each year, and even if Beth is shown not to carry the altered gene,

a certain risk of breast cancer remains. Thus, the decision whether to be

tested is complex and is made more so by uncertainty related to the normal

genetic variation that exists among humans. Our understanding of genetic

factors that can predispose individuals to certain cancers, while increasing,

is still far from complete. The question about whether Beth should request

prophylactic mastectomy of both breasts after she develops cancer in one

breast is equally complex.

108

Web-Based Activities

In Advance

Steps 2 and 3.

Materials and Preparation

Photocopies and Transparencies

Equipment and Materials

• Make 1 copy of Master 5.1 for

• (Optional) Computers

each student*

with Internet access

• Make 1 copy of Master 5.2 for

each student

• Make 1 copy of Master 5.3 for

each student*

*Needed only by classes without access to the Internet.

Follow the instructions on page 110 to get to the Web site on the computers

students will use. If you do not have enough computers with Internet

access, you can use the print-based alternative (on pages 110 and 111).

Tips from the field test

Procedure

Teachers who tested this lesson raised two cautions:

• Students became so engaged in Beth’s story that they lost sight of the

major messages about genetic variation and its relationship to complex

disease. Remind your students that Beth’s difficult decisions arise

because of progress in basic science that allows us to detect such genetic

variations.

• Students tended to confuse the test for mutations in the BRCA1

and BRCA2 genes with a test for cancer itself. Be sure to clarify this

distinction. The genetic test identifies forms of the BRCA1 and BRCA2

genes that can increase one’s likelihood of developing cancer. It is not a

test for cancer.

1. Open the lesson by asking students whether they know anyone who

has had breast cancer. Invite those students who wish to briefly

describe their relationship to that person to do so.

With approximately one in eight American women developing breast

cancer in their lifetimes, it would not be unusual for one or more of

your students to be involved personally with this type of cancer. It

may be that the student’s mother or another family member has had or

currently has cancer. For some of those students, discussions of cancer

may be disturbing. We suggest that you watch your students for signs

of discomfort (for example, tearfulness, reluctance to begin the lesson,

and unusual silence or reticence) and provide appropriate support.

109

Student Lesson 5

Human Genetic Variation

Steps 2 and 3 for classes with access to the Internet:

2. Direct students to organize into their small groups and watch the five

online videos under “Making Decisions in the Face of Uncertainty” (total

running time is about 10 minutes). This first time through, ask students

simply to watch and listen so they can get a sense of the complete case.

Go to http://science.education.nih.gov/supplement/genetic/student and click on “Making Decisions in the Face of Uncertainty” to access the videos.

3. Give each student one copy of Master 5.2, Analyzing the Issues, and

explain that now the class will view the videos again, one segment at

a time. Suggest that students take notes and list questions that occur

to them as they watch each segment, then respond to the related

questions on Master 5.2. Discuss each segment in turn, as students

complete it, using the questions on Master 5.2 as a guide. Address any

other questions the students raise as well.

Steps 2 and 3 for classes without access to the Internet:

2. Give each student one copy of Master 5.1, Making Decisions in the Face

of Uncertainty. Direct students to organize into their small groups

and to select students to read the parts of the various characters.

Ask students simply to read the script all the way through so they

can get a sense of the complete case.

3. Give each student one copy of Master 5.2, Analyzing the Issues, and

one copy of Master 5.3, Reference Database, and explain that now

the class will read the script again, one segment at a time. Suggest

that students take notes and list questions that occur to them as they

read each segment, then respond to the related questions on Master

5.2. Discuss each segment in turn, as students complete it, using the

questions on Master 5.2 as a guide. Address any other questions the

students raise as well.

If students raise questions about the science, legal, or policy issues that

you and they cannot answer with the materials provided, suggest that

someone pursue those answers outside of class.

Segment 1: Considering the Test

Question 1. What decision does Beth have to make?

Beth has to decide whether to have the test for mutations in her BRCA1

and BRCA2 genes. Your students might be interested in the financial

aspects of the test. As of 2010, when this module was reprinted, the

laboratory cost for the combined test for BRCA1 and BRCA2 ranged from

several hundred to several thousand dollars. There would be additional

110

index-119_1.png

costs for the associated genetic counseling. Insurance coverage varies

depending on the company.

Question 2. Who might be affected by Beth’s decision?

Beth, her husband, her mother, her sisters, her teenage daughter, and

her daughter’s future partner (if she has one).

Question 3. What arguments support having the test?

This is a good opportunity to ensure that the students understand the

underlying science in this case study.

For classes with access to the Internet:

The identifi cation of

Files in the online Breast Cancer Database will help students

mutations that predispose

learn about the science. Go to http://science.education.nih.gov/

individuals who carry

supplement/genetic/student and click on “Making Decisions in the

them to cancer is an

Face of Uncertainty” to access the database. Students can access those

excellent example of how

files on their own, if you have enough computers with access to the Internet.

basic research in science

yields results that benefi t

For classes without access to the Internet:

society. As students

Information in Master 5.3, Reference Database, will help

complete the lesson,

students learn about the science.

challenge them to think

Beth will no longer be uncertain about her status with respect to BRCA1

about the benefi ts that

and BRCA2. She will be able to make some other decisions, and she

Beth and her family

will be able to inform other family members about whether they are

gain as a result of this

at risk for carrying a mutated form of one of the genes. Note that Beth

knowledge. Ask students

says, with respect to a potentially negative genetic test, “You find out

that you’re safe.” Ask students to comment on this remark. Emphasize

to summarize their ideas

that this test identifies only one type of risk factor for breast cancer.

as you close the lesson

Simply because one does not have the particular mutations identified

in Step 4.

in this test does not mean that one “is safe” from developing breast

cancer. There likely are other unknown genetic variations that can

increase one’s risk. Furthermore, only a small proportion of breast

cancer is hereditary. Beth’s comment about birth control pills provides

an opportunity to discuss the constantly changing nature of scientific

knowledge and to point out the environmental contributions to cancer.

Question 4. What arguments support not having the test?

Beth may not want to know. She also will not have to worry about

whether she should share potentially positive test results with other

members of the family. She will not have to make tough decisions

about detection and/or prevention options (for example, prophylactic

mastectomy), none of which is 100 percent effective.

Question 5. What factors do you think Beth and Charlie should consider

in making their decisions?

Answers will vary, but be alert for misconceptions about the

underlying science.

111

Student Lesson 5

Human Genetic Variation

Segment 2: A Family Question

Question 1. What new facts have you learned about breast cancer?

In testing for genes related to cancer, it is helpful to test a family

member who already has had the disease. Not all cancers are

heredity. The form of cancer that Beth’s mother has may not be

heredity. If it is hereditary, it may be associated with a gene not

yet identified by scientists.

Question 2. What are some of the family issues that arise in this

counseling session?

Beth’s mother feels guilty about her breast cancer and about the

possibility that she has passed on the associated mutation. The issue of

blame also arises, as well as the question of what Beth will do with the

information if the test is positive. Note that the counselor stresses the

importance of privacy and confidentiality. Emphasize for your students

that genetic counselors are trained to handle the social and emotional

aspects of counseling as well as the scientific aspects.

Question 3. What reasons does the genetic counselor give for not testing

Jennifer? Do you agree that children under 18 should not be tested?

The counselor’s reasons are rather nonspecific, simply that “teenagers

often have different perspectives about developing breast cancer.”

Students’ views on the testing of children under 18 will vary. Insist,

however, that they provide concrete explanations for their positions and

be alert to misunderstandings of the science.

The decision for a healthcare provider to conduct a genetic test is

based on a variety of factors. Healthcare professionals are trained to

reduce risks to their patients, including psychosocial risks. Anxiety

and depression may arise in response to a positive test. A similar issue

received attention in the mid-1980s, when healthcare professionals had

to decide how to handle testing for exposure to the AIDS virus, HIV. At

that point, the connection between a positive test for exposure to HIV

and development of the fatal disease AIDS was not yet clear (although

the correlation has since been established to the satisfaction of virtually

all scientists). Keep in mind that not everyone who inherits an altered

form of BRCA1 or BRCA2 develops breast cancer; thus, knowing that

one carries such an allele may trigger needless anxiety.

Other factors that a healthcare provider considers when discussing

genetic testing include the following questions:

• Can the related disorder, once diagnosed, be treated? In some cases,

for example, Huntington disease, there are no treatments currently

available that can help a person who tests positive.

• Does the patient exhibit symptoms, or is the order for a test based

on family history alone?

112

• Do the benefits outweigh the harm brought about by knowledge of

the test results?

The issue becomes even more complex when the patient to be tested

is a minor, that is, under 18 years of age. The request for a genetic

test may come from the parents or from the minor. When the minor

is an adolescent, the issue becomes particularly complicated because

the patient may exhibit a considerable degree of autonomy regarding

his or her healthcare decisions. Experts agree that in these cases the

primary goal of genetic testing should be to promote the child’s well-

being. For example, the child who tests positive may be overindulged

or may be treated as a scapegoat. Both of these problems can occur,

however, even in the absence of testing. The testing of a child (or indeed

any other family member) also has implications for all members of the

family. In some cases, this forewarning will be welcomed; in others, it

may be unwanted. Genetic testing of a child will ease some aspects of

uncertainty, but people differ greatly in their response to such news.

In the case of genetic testing for mutations in the BRCA1 gene, most

healthcare providers and genetic-testing centers adhere to a policy that

denies tests to minors. This denial extends to requests from the parents,

who are the legal guardians of the child’s health. The psychological

effects can be mixed. Whereas some individuals prefer the release from

uncertainty, others could view a positive result as a death sentence

and react in ways that are destructive to themselves or their families.

Genetic testing requires informed consent, and some geneticists

argue that this requirement automatically rules out children, and

even teenagers, who generally are judged incapable of providing such

consent. This view of minors, however, may be far too broad and may

not be realistic. Some specialists are beginning to recognize that some

adolescents and young children have sufficient autonomy in consent

and decision making to make such decisions, and recommend that the

desires of these youths should be taken into account. In any event, one

must weigh the balance of potential harm and benefit in reaching a

decision about testing a minor.

One outcome of the current policy is to delay the decision to test until

the individual is an adult and can make the decision, rather than letting

parents remove this option by making the choice themselves. Note that

a change in policy most likely would result in parents being permitted

to make the decision, rather than leaving the decision to the minor in

question. Either way, issues of ethical decision making will arise.

Question 4. Beth’s mother says, “I’m not sure more information is better.”

Do you agree with her? Explain your answer.

Answers will vary.

113

Student Lesson 5

Human Genetic Variation

Segment 3: The Test Results

Question 1. Beth and her mother have had the genetic test. What new

information have we learned?

Beth and her mother are positive for the BRCA1 mutation. Beth has a

lifetime risk of perhaps about 60 percent of developing breast cancer.

This number is down from original estimates, which were as high as

90 percent. Some recent data suggest a risk figure even lower than

60 percent. In fact, as is often true when a new medical test becomes

available, the exact figure is still unknown. Further, it appears that the

risk figure may vary, depending upon the particular mutation in the

BRCA1 gene that an individual woman carries.

Students have also learned that Beth may not develop breast cancer even

though her test was positive and that Beth can do a number of things

(breast self-examinations and mammograms, for example) to help

detect any cancer early and, therefore, to begin early treatment.

Remember to emphasize that Beth and her mother were tested for

mutations in the BRCA1 and BRCA2 genes, not for cancer.

Segment 4: A Diagnosis of Breast Cancer

Question 1. What new information have we learned about Beth?

It is now three years after the genetic test, and Beth has been

diagnosed with cancer in one breast. There is a high risk of cancer

in the other breast.

Question 2. What major decisions do Beth and her husband discuss in

this segment?

First, they discuss whether Beth should have both breasts removed,

and second, they consider whether to tell Jennifer that she is at risk for

the BRCA1 mutation. Note that even removal of both breasts does not

guarantee that the cancer will not appear elsewhere or even appear in

the remaining breast tissue.

Question 3. What do you think Beth and Charlie should do? Why?

Answers will vary, but make certain that students provide sound

explanations for their positions. Again, make sure that the science

is correct.

114

Segment 5: Jennifer’s Decision

Question 1. What new information emerges in this segment?

Beth has had a lumpectomy, and Jennifer has not been tested.

Emphasize that the chance of survival increases with early diagnosis.

Question 2. What is Jennifer’s primary concern about the test?

She is concerned that potential employers and insurers will discriminate

against her if they find out she has a high relative risk for breast cancer.

Question 3. Do you think employers or insurers should be able to deny

employment or insurance to a person who has a genetic predisposition to

a disease such as cancer? Explain your position.

Answers will vary. Inform students that at present many states have

laws that prohibit health insurers from accessing and using genetic

information in a discriminatory way. In addition, the federal Health

Insurance Portability and Accountability Act (HIPAA) prohibits those

who issue commercial, employer-based, group health plans from

discriminating against individuals on the basis of information gained

from genetic tests.

Regarding employment discrimination, the Equal Employment

Opportunity Commission extends Americans with Disabilities

protection to individuals who experience discrimination based on

genetic information related to illness, disease, or other disorders.

4. Close the lesson by challenging students to identify the questions

that now face Jennifer, Beth’s daughter, about her own health and

personal welfare. Encourage students to think deeply about these

questions. For each question that they identify as facing Jennifer,

have them determine her options and begin to identify arguments

Use students’ answers to

that she might use in support of choosing one option over the other.

these questions to assess

Invite neighboring groups to discuss these questions. Then, use the

their understanding of the

following questions to stimulate a brief, final class discussion about

lesson’s major concepts.

the lesson.

• Our understanding of and ability to identify genetic differences

among us has increased remarkably in the past few decades and

continues to increase. How might Beth’s and Jennifer’s decisions

have been different 50 years ago? What advantages does our

knowledge of human genetic variation bring us? What questions

does it also raise?

Fifty years ago, Beth and Jennifer would not have been faced with

the decision about whether to have these genetic tests. They most

likely would have undergone a radical mastectomy if cancer was

discovered. Our increased knowledge of human genetic variation

115

Student Lesson 5

Human Genetic Variation

has improved our understanding of the relationship between certain

variations and disease and enabled us to test for some of these

genetic variations. New knowledge a